A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Psychopharmacology studies how drugs alter brain function and behavior by interacting with neurotransmitter systems. Pharmacokinetics describes how the body processes a drug — absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics describes how the drug affects neural systems — its mechanism of action at receptors or transporters. The dose-response curve captures the relationship between dose and effect, with therapeutic windows, ceiling effects, and lethal doses all clinically relevant. Repeated drug exposure leads to tolerance (reduced response) through receptor downregulation or desensitization.
Trace the journey of a drug from administration to effect: oral ingestion → absorption → blood-brain barrier crossing → receptor binding → downstream neural effects → behavior. The blood-brain barrier's lipid solubility requirement explains why many potential drugs fail to reach the CNS.
You already understand neurotransmitters, receptors, and synaptic transmission. Psychopharmacology is built on a simple question: what happens when an exogenous chemical enters this system? To answer it, you need two complementary frameworks — what the body does to the drug (pharmacokinetics) and what the drug does to the brain (pharmacodynamics).
Pharmacokinetics follows the ADME sequence. A drug is absorbed into the bloodstream, distributed to tissues including the brain, metabolized (chemically transformed, often in the liver) into active or inactive compounds, and excreted (typically via urine). The critical gateway for psychoactive drugs is the blood-brain barrier — a tight junction of specialized endothelial cells that surrounds brain capillaries. Unlike most of the body, the CNS is highly selective about what it admits. The barrier's lipid-rich environment means only small, lipid-soluble molecules cross freely. This is why morphine reaches the brain rapidly (highly lipid-soluble) while many antibiotics do not. Route of administration matters too: intravenous injection bypasses absorption entirely, reaching peak blood concentrations immediately; oral ingestion is slower because the drug must survive stomach acid and first-pass liver metabolism before entering circulation.
Pharmacodynamics describes how the drug alters neural signaling once it arrives. Building on your receptor knowledge: drugs can act as agonists (mimicking the endogenous ligand by binding and activating the receptor), antagonists (binding without activating, blocking the endogenous ligand), or reuptake inhibitors (blocking the transporter that clears neurotransmitter from the synapse, thereby prolonging its effect). The dose-response curve captures the relationship between drug concentration and effect, characterized by the EC50 (dose producing half-maximal effect), the maximum effect (ceiling), and the therapeutic window — the range between effective and toxic doses. Narrow therapeutic windows require careful dosing; lithium, used for bipolar disorder, is notorious for this.
Repeated exposure produces tolerance: the same dose produces a diminished effect over time. Tolerance reflects the brain's attempt to maintain homeostasis. When a drug repeatedly floods dopamine receptors, neurons compensate by downregulating receptor density or reducing neurotransmitter synthesis — the brain recalibrates around the drug's presence. Remove the drug and the system is now under-activated relative to baseline: this is withdrawal, a state opposite in quality to the drug's acute effects. Stimulant withdrawal causes fatigue and depression; opioid withdrawal causes pain and anxiety. Crucially, tolerance and withdrawal together constitute physical dependence — but dependence is not the same as addiction. A patient on long-term opioids for chronic pain may be physically dependent (would experience withdrawal if abruptly stopped) without showing the compulsive drug-seeking that defines addiction. The distinction matters clinically and morally.